SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-052681
Filing Date
2021-04-21
Accepted
2021-04-20 18:48:30
Documents
2
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2113547d1_6k.htm 6-K 11396
2 EXHIBIT 99.1 tm2113547d1_ex99-1.htm EX-99.1 84524
  Complete submission text file 0001104659-21-052681.txt   97118
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 21839062
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences